Life Sciences Tools & Diagnostics

Return to Healthcare Areas of Focus

Baird's Life Sciences Tools & Diagnostics practice is a trusted and respected resource for a wide breadth of public and private clients. We have helped a wide range of Life Science and Diagnostics companies with financing and M&A transactions. Our transaction outcomes have been consistently outstanding and our clients highly satisfied. We have the best team and culture to make outstanding outcomes a reality.

VIEW OUR LIFE SCIENCES & DIAGNOSTICS RESEARCH COVERAGE

Recent Transactions

Avidity Science Is Acquired by ATS

Natera Completes $250.3 Million Follow-On Offering

AeroSafe Raises Series F Funding

Kova Is Acquired by LGC

Natera Completes $460 Million Follow-On Offering

AEA Has Acquired BPG From CGIF

Valuence Completes $220 Million IPO

Maravai Completes $1 Billion Follow-On Offering

RumbleOn Completes $167 Million Follow-On Offering

PartsSource Sold to Bain

VeraSci Sold to WCG

BioDot Is Acquired By ATS

Vigene Is Acquired By Charles River

Maravai Completes $647 Million Follow-On Offering

eMolecules Receives Investment From Avista

StatLab Is Acquired By Audax and Linden

Castle Completes $266.8 Million Follow-On Offering

Arcturus Completes $150 Million Follow-On Offering

Twist Completes $323.7 Million Follow-On Offering

Maravai Completes $1.863 Billion Initial Public Offering

NanoString Completes $230 Million Follow-On Offering

Natera Completes $287.5 Million Follow-On Offering

Arcturus Completes $200 Million Follow-On Offering

Castle Completes $85.1 Million Follow-On Offering

View More Transactions

Contact a Member of Our Team

Ryan Mausehund Managing Director

View Profile

Robert Andrews Managing Director Co-Head of Global Healthcare Group

View Profile

News & Insights

            
Baird Global Investment Banking Adds Martin Moser to Healthcare TeamNew Director to enhance European Industry Coverage from Frankfurt 

        Keep Reading 
    
Baird Healthcare IT: Record-Breaking Year and Strong MomentumIn 2021, the Baird Healthcare IT team completed 22 transactions representing $10+ billion in transaction value.

        Keep Reading 
    
Baird’s European Healthcare Team off to a Stellar Start in 2022Staring the year off strong, Baird’s European Healthcare team has successfully signed four deals in the past four months.

        Keep Reading

Learn More About Our Offerings

M&A

Equity

Capital Advisory

Restructuring Advisory